Evaluation of pathological complete response as a surrogate endpoint for overall survival in resectable oesophageal cancer: integrated analysis of individual patient data from phase III trials

Journal:

British Journal of Surgery

Published:

2025-05-31

DOI:

10.1093/bjs/znaf131

Affiliations:

16

Authors:

20

Go to article

Institutions	Authors	Share
Keio University, Japan	5.000000	0.25
Zhongshan Hospital, Fudan University, China	2.000000	0.10
Erasmus University Medical Center (Erasmus MC), Netherlands	2.000000	0.10
Keio University Hospital, Japan	1.000000	0.05
Charité - University Medicine Berlin, Germany	1.000000	0.05
Karolinska Institute (KI), Sweden	1.000000	0.05
Karolinska University Hospital, Sweden	1.000000	0.05
Hôpital Saint-Louis, France	1.000000	0.05
Cancer Heterogeneity, Plasticity and Resistance to Therapies (CANTHER), France	1.000000	0.05
Erasmus MC Cancer Institute, Netherlands	1.000000	0.05
Shizuoka Cancer Center, Japan	1.000000	0.05
Hamamatsu University School of Medicine, Japan	1.000000	0.05
National Cancer Center Hospital, Japan	1.000000	0.05
Swiss Group for Clinical Cancer Research (SAKK), Switzerland	0.500000	0.03
University of Basel (UB), Switzerland	0.500000	0.03

Interested in Oncology and Carcinogenesis?